Sitemap

September 11, 2002 Articles

Filter by Available Specialty
  1. Botox ad claims misleading, FDA says; ads will stay, says Allergan
  2. Tecnis IOL offers better contrast sensitivity than other IOLs
  3. ThinOptX receives CE mark in Europe
  4. Zyoptix reduces higher-order aberrations, study finds